S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

GILD Gilead Sciences Inc

114.20

2.21 (1.97%)

01 Mar 2025 - Closed

Delayed by 15 minutes

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Gilead Sciences Charts.

Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Gilead Sciences Charts.

Gilead Sciences Inc News

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Saturday 1 March 2025 (10 hours ago) • Edgar (US Regulatory)

European Medicines Agency Validates Gilead’s Marketing Authorization Application and EU-Medicines for All Application for Twice-Yearly Lenacapavir for HIV Prevention
Tuesday 25 February 2025 (5 days ago) • Business Wire

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Friday 21 February 2025 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 21 February 2025 (1 week ago) • Edgar (US Regulatory)

Gilead’s Seladelpar Granted Conditional European Marketing Authorization for the Treatment of Primary Biliary Cholangitis
Friday 21 February 2025 (1 week ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 20 February 2025 (1 week ago) • Edgar (US Regulatory)

Gilead Sciences to Present at Upcoming Investor Conferences
Thursday 20 February 2025 (1 week ago) • Business Wire

Form 144 - Report of proposed sale of securities
Wednesday 19 February 2025 (1 week ago) • Edgar (US Regulatory)

U.S. FDA Accepts Gilead’s New Drug Applications for Twice-Yearly Lenacapavir for HIV Prevention Under Priority Review
Wednesday 19 February 2025 (2 weeks ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Friday 14 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 14 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 13 February 2025 (2 weeks ago) • Edgar (US Regulatory)

More Gilead Sciences Inc News Articles

Groupe Bruxelles Lambert (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions